Genelux (GNLX) Accumulated Expenses (2022 - 2026)
Genelux (GNLX) recorded quarterly Accumulated Expenses of $861000.0 in Q1 2026, down 40.21% quarter-over-quarter from $1.4 million in Q4 2025.
Genelux (GNLX) Accumulated Expenses (2022 - 2026) Analysis & Trends
Genelux's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $861000.0 for Q1 2026.
- In Q1 2026, Accumulated Expenses changed N/A year-over-year to $861000.0; the TTM figure through Mar 2026 stood at $861000.0 (changed N/A YoY), while the FY2025 annual figure was $1.4 million, down 78.1% from the prior year.
- Accumulated Expenses was $861000.0 for Q1 2026 at Genelux, down from $1.4 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $6.6 million in Q4 2024 to a low of $517000.0 in Q2 2024.
- Historically, Accumulated Expenses has averaged $1.9 million across 5 years, with a median of $1.2 million in 2022.
- Biggest YoY gain for Accumulated Expenses was 210.53% in 2024; the steepest drop was 83.27% in 2024.
- A 5-year view of Accumulated Expenses shows it stood at $1.2 million in 2022, then jumped by 79.71% to $2.1 million in 2023, then jumped by 210.53% to $6.6 million in 2024, then sank by 78.1% to $1.4 million in 2025, then sank by 40.21% to $861000.0 in 2026.
- The last three Accumulated Expenses figures came in at $861000.0 (Q1 2026), $1.4 million (Q4 2025), and $800000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 861,000.00 |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 610,000.00 |
| Dec 31, 2024 | 6.57 Mn |
| Sep 30, 2024 | 686,000.00 |
| Jun 30, 2024 | 517,000.00 |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 2.12 Mn |
| Sep 30, 2023 | 4.10 Mn |
| Dec 31, 2022 | 1.18 Mn |